RenovoRx (RNXT) News Today $1.22 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$1.23 +0.01 (+0.41%) As of 05:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock RNXT Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period RenovoRx's (RNXT) "Buy" Rating Reaffirmed at HC WainwrightMay 20 at 1:51 AM | americanbankingnews.comEarnings call transcript: RenovoRx Q1 2025 revenue exceeds expectationsMay 17, 2025 | investing.comRenovoRx, Inc. (NASDAQ:RNXT) Q1 2025 Earnings Call TranscriptMay 17, 2025 | msn.comRenovoRx Inc (RNXT) Q1 2025 Earnings Call Highlights: Promising Revenue Growth and Clinical ...May 16, 2025 | finance.yahoo.comLe BPA de RenovoRx a dépassé les attentes, le CA en dessous des prévisionsMay 15, 2025 | fr.investing.comTranscription des résultats : le chiffre d’affaires de RenovoRx au T1 2025 dépasse les attentesMay 15, 2025 | fr.investing.comRenovoRx, Inc. (RNXT) Q1 2025 Earnings Conference Call TranscriptMay 15, 2025 | seekingalpha.comRenovoRx Reports First Quarter 2025 Financial Results and Business HighlightsMay 15, 2025 | businesswire.comEarnings Preview For RenovoRxMay 14, 2025 | benzinga.comRenovoRx to Participate in Fireside Chat at A.G.P. Virtual Healthcare Company Showcase on May 21stMay 14, 2025 | finance.yahoo.comU.S. Patent Office Issues New Patent to RenovoRx for Novel Trans-Arterial Micro-Profusion (TAMP™) Therapy PlatformMay 6, 2025 | finance.yahoo.comJohns Hopkins rejoint l’essai TIGeR-PaC de RenovoRx sur le cancer du pancréasApril 29, 2025 | fr.investing.comJohns Hopkins Medicine Initiates Patient Enrollment for RenovoRx’s Ongoing Phase III TIGeR-PaC Clinical TrialApril 29, 2025 | finance.yahoo.comRenovoRx ramps up production of FDA-cleared RenovoCathApril 18, 2025 | uk.investing.comRamtin Agah Purchases 15,000 Shares of RenovoRx, Inc. (NASDAQ:RNXT) StockApril 18, 2025 | insidertrades.comLe directeur médical de RenovoRx, Agah Ramtin, achète des actions pour 13.500$April 18, 2025 | fr.investing.comLe directeur médical de RenovoRx, Agah Ramtin, achète des actions ordinaires pour 13.500€April 18, 2025 | fr.investing.comLe PDG de RenovoRx, Shaun Bagai, acquiert des actions ordinaires pour 6.821$April 16, 2025 | fr.investing.comRenovoRx augmente la production de son dispositif RenovoCath approuvé par la FDAApril 16, 2025 | fr.investing.comRenovo Gains on Bringing Forward RenovoCathApril 16, 2025 | baystreet.caRenovoRx, Inc. (NASDAQ:RNXT) Insider Acquires $16,000.00 in StockApril 15, 2025 | insidertrades.comLe directeur médical de RenovoRx, Ramtin Agah, achète des actions pour 16.000$April 14, 2025 | fr.investing.comRenovoRx, Inc. (NASDAQ:RNXT) Director Laurence Marton Purchases 12,050 SharesApril 11, 2025 | insidertrades.comRenovoRx, Inc. (NASDAQ:RNXT) Insider Buys $21,840.00 in StockApril 10, 2025 | insidertrades.comLe directeur médical de Renovorx, Agah Ramtin, achète des actions pour 21.840$April 9, 2025 | fr.investing.comLe PDG de RenovoRx, Shaun Bagai, achète pour 8.300$ d’actions de la sociétéApril 8, 2025 | fr.investing.comL’action RenovoRx atteint son plus bas niveau sur 52 semaines à 0,77$April 8, 2025 | fr.investing.comH.C. Wainwright maintains Buy rating on RenovoRx stockApril 6, 2025 | uk.investing.comH.C. Wainwright maintient sa recommandation d’achat sur l’action RenovoRxApril 5, 2025 | fr.investing.comRenovoRx to Present at LD Micro Invitational XV Conference in New York on April 10thApril 4, 2025 | finance.yahoo.comRenovoRx prévoit une croissance grâce à de nouvelles commandes et essais cliniquesApril 1, 2025 | fr.investing.comRenovoRx Reports Initial Revenues from RenovoCath® Commercialization, and Provides Update on Ongoing Pivotal Phase III TIGeR-PaC Clinical TrialApril 1, 2025 | businesswire.comRenovoRx Highlights New Human Pharmacokinetic Data Abstract at SSO 2025 Annual MeetingMarch 28, 2025 | businesswire.comHC Wainwright & Co. Initiates Coverage of RenovoRx (RNXT) with Buy RecommendationMarch 28, 2025 | msn.comRenovoRx honorée pour sa recherche sur le traitement du cancerMarch 27, 2025 | fr.investing.comRenovoRx Advances Commercialization of RenovoCath® with Several New Purchase Orders, Including Customer ReordersFebruary 27, 2025 | finance.yahoo.comRenovoRx Advances Commercialization of RenovoCath® with Several New Purchase Orders, Including Customer ReordersFebruary 26, 2025 | businesswire.comRenovoRx presents data from Trans-Arterial Micro-Perfusion therapy platformFebruary 13, 2025 | markets.businessinsider.comRenovoRx Announces Closing of $12.1 Million Underwritten Public Offering of Common StockFebruary 12, 2025 | finance.yahoo.comRenovoRx 11.52M share Spot Secondary priced at $1.05February 7, 2025 | msn.comRenovoRx Announces Pricing Of Public Offering Of About 11.52 Million Shares At $1.05/shrFebruary 7, 2025 | markets.businessinsider.comRenovoRx lance une offre publique d'actionsFebruary 6, 2025 | fr.investing.comRenovoRx launches public stock offeringFebruary 6, 2025 | msn.comRenovoRx announces common stock offering, no amount givenFebruary 6, 2025 | markets.businessinsider.comRenovoRx Announces Pricing of $12.1 Million Underwritten Public Offering of Common StockFebruary 6, 2025 | businesswire.comRenovoRx Announces Proposed Public OfferingFebruary 6, 2025 | finance.yahoo.comRenovoRx Announces Proposed Public OfferingFebruary 6, 2025 | businesswire.comRenovoRx: From Clinical Promise To Commercial Reality And Trading At A Significant DiscountFebruary 5, 2025 | seekingalpha.comAnalysts Expect Breakeven For RenovoRx, Inc. (NASDAQ:RNXT) Before LongJanuary 23, 2025 | finance.yahoo.comRenovoRx Continues to Grow Intellectual Property Portfolio for its Novel Drug-Delivery Therapy PlatformDecember 30, 2024 | finance.yahoo.com Get RenovoRx News Delivered to You Automatically Sign up to receive the latest news and ratings for RNXT and its competitors with MarketBeat's FREE daily newsletter. Email Address RNXT Media Mentions By Week RNXT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RNXT News Sentiment▼0.190.66▲Average Medical News Sentiment RNXT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RNXT Articles This Week▼111▲RNXT Articles Average Week Get RenovoRx News Delivered to You Automatically Sign up to receive the latest news and ratings for RNXT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies FDMT News ENGN News PBYI News LFVN News KRRO News SLS News FTLF News NKTX News CYBN News TNGX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RNXT) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RenovoRx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RenovoRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RNXT Stock Free RNXT Stock Alerts